Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 15
1956 112
1957 212
1958 250
1959 302
1960 287
1961 251
1962 244
1963 415
1964 512
1965 380
1966 412
1967 420
1968 456
1969 466
1970 429
1971 478
1972 445
1973 497
1974 520
1975 406
1976 402
1977 360
1978 384
1979 334
1980 319
1981 358
1982 359
1983 374
1984 451
1985 448
1986 437
1987 439
1988 477
1989 515
1990 553
1991 526
1992 604
1993 588
1994 596
1995 548
1996 590
1997 545
1998 638
1999 604
2000 669
2001 650
2002 706
2003 750
2004 749
2005 803
2006 770
2007 816
2008 825
2009 828
2010 854
2011 867
2012 934
2013 801
2014 814
2015 739
2016 713
2017 704
2018 700
2019 325
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

32,496 results
Results by year
Filters applied: . Clear all
Page 1
Prednisolone Versus Dexamethasone for Croup: a Randomized Controlled Trial.
Parker CM and Cooper MN. Pediatrics 2019 - Clinical Trial. PMID 31416827
In this study, we compare dexamethasone at 0.6 mg/kg with both low-dose dexamethasone at 0.15 mg/kg and prednisolone at 1 mg/kg. ...RESULTS: Mean Westley Croup Score at baseline was 1.4 for dexamethasone, 1.5 for low-dose dexamethasone, and 1.5 for prednisolone. ...
In this study, we compare dexamethasone at 0.6 mg/kg with both low-dose dexamethasone at 0.15 mg/kg and prednisolone at 1 mg/kg. ...R …
Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Miyata K, et al. Lancet Child Adolesc Health 2018 - Clinical Trial. PMID 30337183
Serious adverse events were reported in 12 (1·7%) of 724 patients treated with primary IVIG plus prednisolone; two of these patients had hypertension and bacteraemia that was probably related to prednisolone. ...A primary IVIG and prednisolone combination therapy might prevent coronary artery abnormalities and contribute to lowering medical costs. ...
Serious adverse events were reported in 12 (1·7%) of 724 patients treated with primary IVIG plus prednisolone; two of these patients …
MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia
Radhakutty A and Burt MG. Eur J Endocrinol 2018 - Review. PMID 30299889
The semi-synthetic glucocorticoid prednisolone is most commonly prescribed and in two main patterns. Prednisolone is prescribed short term at medium-high doses to treat an acute inflammatory illness or long term at lower doses to attenuate chronic inflammatory disease progression. ...If treatment is indicated, metformin has been shown to be effective and may attenuate other adverse effects of long-term prednisolone therapy. ...
The semi-synthetic glucocorticoid prednisolone is most commonly prescribed and in two main patterns. Prednisolone is prescribe …
Canine T cell lymphoma treated with lomustine, vincristine, procarbazine, and prednisolone chemotherapy in 35 dogs.
Morgan E, et al. Vet Comp Oncol 2018. PMID 30117253
The cyclophosphamide, doxorubicin, vincristine, and prednisolone protocol is widely accepted as a first line treatment for canine lymphoma. ...This study investigated the use of a modified lomustine, vincristine, procarbazine and prednisolone protocol as a first line treatment in 35 dogs with T Cell lymphoma. ...
The cyclophosphamide, doxorubicin, vincristine, and prednisolone protocol is widely accepted as a first line treatment for canine lym …
Glucocorticoids for croup in children
Gates A, et al. Cochrane Database Syst Rev 2018. PMID 30133690 Free PMC article.
Deflazacort versus prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post HOC analysis from the ACT DMD trial.
Shieh PB, et al. Muscle Nerve 2018 - Clinical Trial. PMID 30028519 Free PMC article.
This post hoc analysis compares efficacy and safety for deflazacort and prednisone/prednisolone in the placebo arm. METHODS: Patients received deflazacort (n = 53) or prednisone/prednisolone (n = 61). ...Mean changes in 4-stair climb were 3.79 s (deflazacort; 95% CL, 1.54, 6.03) and 6.67 s (prednisone/prednisolone; 95% CL, 4.69, 8.64). ...
This post hoc analysis compares efficacy and safety for deflazacort and prednisone/prednisolone in the placebo arm. METHODS: Patients …
Management of steroid-resistant nephrotic syndrome in children and adolescents
Tullus K, et al. Lancet Child Adolesc Health 2018 - Review. PMID 30342869
Patients who do not show remission after 4 weeks' treatment with daily prednisolone are considered to have steroid-resistant nephrotic syndrome (SRNS). ...
Patients who do not show remission after 4 weeks' treatment with daily prednisolone are considered to have steroid-resistant nephroti …
Extended course of prednisolone in infants with severe bronchopulmonary dysplasia.
Linafelter A, et al. Early Hum Dev 2019. PMID 31265946
The average age at start of prednisolone treatment was 42.5 ± 5.9 weeks; while the median duration and median cumulative dose of prednisolone therapy were 67 (IQR 57-107) days and 61.3 (IQR 39.9-93.3) mg/kg, respectively. ...CONCLUSIONS: In one of the first reports on prednisolone therapy for severe BPD, we describe that long-term prednisolone is associated with modest short-term improvement in PSS, but impairs linear growth. ...
The average age at start of prednisolone treatment was 42.5 ± 5.9 weeks; while the median duration and median cumulative dose of p
32,496 results
Jump to page
Feedback